{"brief_title": "Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.", "brief_summary": "The purpose of this study is to assess the Safety, Tolerability and Efficacy of ZD6126 in Combination with Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects with Metastatic Colorectal Cancer.", "condition": "Metastases, Neoplasm", "intervention_type": "Drug", "intervention_name": "oxaliplatin", "criteria": "Inclusion Criteria: - Metastatic colorectal carcinoma - Suitable for first-line treatment of metastatic disease Exclusion Criteria: - Peripheral neuropathy greater than Grade 1 - Adjuvant therapy within 6 months prior to study treatment - Prior oxaliplatin - Prior pelvic or whole abdomen radiation - Any history of coronary angioplasty or history of myocardial infarction", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00065117.xml"}